These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 34210965)
21. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging. Zhang H; Lin X; Zha S Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996 [TBL] [Abstract][Full Text] [Related]
22. High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair. Dhakar SS; Galera-Prat A; Lehtiö L Sci Rep; 2024 Feb; 14(1):3875. PubMed ID: 38365924 [TBL] [Abstract][Full Text] [Related]
23. ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification. Rouleau-Turcotte É; Pascal JM J Biol Chem; 2023 Dec; 299(12):105397. PubMed ID: 37898399 [TBL] [Abstract][Full Text] [Related]
24. Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3. Richards F; Llorca-Cardenosa MJ; Langton J; Buch-Larsen SC; Shamkhi NF; Sharma AB; Nielsen ML; Lakin ND Nat Commun; 2023 Jul; 14(1):4310. PubMed ID: 37463936 [TBL] [Abstract][Full Text] [Related]
26. An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation. Bonfiglio JJ; Leidecker O; Dauben H; Longarini EJ; Colby T; San Segundo-Acosta P; Perez KA; Matic I Cell; 2020 Nov; 183(4):1086-1102.e23. PubMed ID: 33186521 [TBL] [Abstract][Full Text] [Related]
27. The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks. Blessing C; Mandemaker IK; Gonzalez-Leal C; Preisser J; Schomburg A; Ladurner AG Mol Cell; 2020 Dec; 80(5):862-875.e6. PubMed ID: 33275888 [TBL] [Abstract][Full Text] [Related]
28. The HPF1-dependent histone PARylation catalyzed by PARP2 is specifically stimulated by an incised AP site-containing BER DNA intermediate. Kurgina TA; Moor NA; Kutuzov MM; Lavrik OI DNA Repair (Amst); 2022 Dec; 120():103423. PubMed ID: 36356486 [TBL] [Abstract][Full Text] [Related]
29. PARP1: Structural insights and pharmacological targets for inhibition. Spiegel JO; Van Houten B; Durrant JD DNA Repair (Amst); 2021 Jul; 103():103125. PubMed ID: 33940558 [TBL] [Abstract][Full Text] [Related]
30. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs. Rudolph J; Roberts G; Luger K Nat Commun; 2021 Feb; 12(1):736. PubMed ID: 33531508 [TBL] [Abstract][Full Text] [Related]
31. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842 [TBL] [Abstract][Full Text] [Related]
32. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity. Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600 [TBL] [Abstract][Full Text] [Related]
33. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways. Ghosh R; Roy S; Kamyab J; Danzter F; Franco S DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144 [TBL] [Abstract][Full Text] [Related]
34. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage. Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748 [TBL] [Abstract][Full Text] [Related]
35. PARP trapping is governed by the PARP inhibitor dissociation rate constant. Gopal AA; Fernandez B; Delano J; Weissleder R; Dubach JM Cell Chem Biol; 2024 Jul; 31(7):1373-1382.e10. PubMed ID: 38262416 [TBL] [Abstract][Full Text] [Related]
36. A Single-Molecule Atomic Force Microscopy Study of PARP1 and PARP2 Recognition of Base Excision Repair DNA Intermediates. Sukhanova MV; Hamon L; Kutuzov MM; Joshi V; Abrakhi S; Dobra I; Curmi PA; Pastre D; Lavrik OI J Mol Biol; 2019 Jul; 431(15):2655-2673. PubMed ID: 31129062 [TBL] [Abstract][Full Text] [Related]
37. Activation of PARP2/ARTD2 by DNA damage induces conformational changes relieving enzyme autoinhibition. Obaji E; Maksimainen MM; Galera-Prat A; Lehtiö L Nat Commun; 2021 Jun; 12(1):3479. PubMed ID: 34108479 [TBL] [Abstract][Full Text] [Related]
38. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage. Matkarimov BT; Zharkov DO; Saparbaev MK Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485 [TBL] [Abstract][Full Text] [Related]
39. The expanding universe of PARP1-mediated molecular and therapeutic mechanisms. Huang D; Kraus WL Mol Cell; 2022 Jun; 82(12):2315-2334. PubMed ID: 35271815 [TBL] [Abstract][Full Text] [Related]